AnaptysBio Inc.
World Rank (Jan-05-2024)
11,751
Market Cap (Jan-05-2024)
0.575 Billion USD
World Rank (Jul-30-2023)
13,367
Market Cap (Jul-30-2023)
0.453 Billion USD
World Rank (Dec-25-2022)
9,383
Market Cap (Dec-25-2022)
0.831 Billion USD
World Rank (Jan-07-2022)
9,972
Market Cap (Jan-07-2022)
0.91 Billion USD
Annual Revenue in USD
63 Million USD
Annual Net Income in USD
-57 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Company Profile
AnaptysBio is a Clinical Stage Biotechnology company developing first in class immunology therapeutic product candidates to patients. The company annual revenue is 75 million USD and 89 employees as on 2020. The headquarters is in USA.
Company Website